It was observed that simultaneous blockage of LAG-3 activity and anti-PD-1 or PD-L1 in tumor cells has dual inhibitory effects, including inhibiting Treg activity, promoting dendritic cells (DCs) maturation, and rescuing dysfunctional CD4+/CD8+ T cells (18–20). The gene discussed is CD4; the disease is neoplasm.